ADM ENDEAVORS, INC. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data ADM ENDEAVORS, INC. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	0.19	3.24	3.56	3.82	5.04	6.56	5.62	5.19	5.76	5.62
Cost of revenue	0.05	0.03	2.17		3.04	3.99	3.78	3.68	3.74	3.74
Gross profit	0.14	1.12	1.45		1.99	2.57	1.84	1.51	2.02	1.89
Selling and marketing		0.18	0.1	0.15	0.2	0.21	0.06	0.04	0.04	0.04
General and administrative	0.13	0.75	1.33	1.36	1.91	1.64	1.43	1.38	1.59	1.61
Operating expenses	0.9	0.93	3.57	3.55	5.16
Operating income	-0.76	0.19	-0.01	0.27	-0.12	0.72	0.35	0.09	0.39	0.25
Interest expense	0.01	0.01	0.11	0.01	0
Other non-operating income	-0.01	-0.01	-0.22	-0.01	0	0.17	-0.13	0.08	-0	0.29
Pre-tax income	-0.77	0.19	-0.23	0.26	-0.12	0.88	0.22	0.17	0.39	0.53
Income tax		0.03		0.03	0	0.15	0.07	0.04	0.07	0.05
Net income	-0.77	0.15	-0.35	0.38	-0.02	0.74	0.15	0.14	0.32	0.49
EBITDA	-0.76	0.23	0.03	0.32	-0.05	0.77	0.39	0.16	0.47	0.35
EPS, basic	-0.01	-0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EPS, diluted	-0.01	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Shares, basic (weighted)	126	128	96.1	135	149	163	154	156	157	157
Shares, diluted (weighted)	126	20	96.1	185	149	187	180	156	184	184

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	0.08	0.05	0.02	0.28	0.28	0.42	0.23	0.3	0.41	0.36
Receivables	0	0.28	0.24	0.07	0.07	0.71	0.36	0.42	0.37	0.41
Inventory		0.01	0.09	0.14	0.21	0.14	0.17	0.17	0.35	0.54
Other current assets					0	0.04	0.04	0.03	0.1	0.17
Total current assets	0.02	0.35	0.38	0.51	0.77	1.35	0.83	0.92	1.27	1.48
Property, plant and equipment	0.02	0.12	0.22	0.22	1.12	1.38	2.83	3.23	5.46	8.66
Lease right-of-use assets				0.03			0.05	0.02
Goodwill			0.69	0.69	0.69	0.69	0.69	0.69	0.69	0.69
Total assets	0.03	0.47	1.29	1.44	2.58	3.41	4.4	4.85	7.42	10.9
Accounts payable	0.07	0.08	0.06	0.02	0	0.02	0.07
Accrued liabilities	0.08	0.1	0.31	0.2	0.17	0.35	0.32	0.37	0.35	0.51
Total current liabilities	0.24	0.28	0.92	0.55	1.03	1.04	0.84	0.87	0.89	1.35
Long-term debt	0.01	0.01	0.01			0.09	1.08	1.23	3.46	5.92
Lease liabilities							0.02
Total liabilities	0.25	0.31	1.01	0.66	1.03	1.12	1.96	2.15	4.37	7.28
Total debt		0.01				0.31
Paid-in capital	14.9	0.08	0.43	0.54	1.31	1.32	1.32	1.43	1.45	1.53
Retained earnings	-15.2	0.08	-0.27	0.1	0.08	0.82	0.97	1.1	1.43	1.91
Shareholders' equity	0.01	0.16	0.28	0.78	1.55	2.29	2.44	2.71	3.05	3.6
Total equity	0.01	0.16	0.28	0.78	1.55	2.29	2.44	2.71	3.05	3.6
Total liabilities and equity	0.03	0.47	1.29	1.44	2.58	3.41	4.4	4.85	7.42	10.9
Shares outstanding	123	0	136	136	164	154	154	156	157	159

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	-0.77	0.15	-0.35	0.38	-0.02	0.74	0.15	0.14	0.32	0.49
Depreciation and amortization	0.01	0.04	0.03	0.05	0.07	0.06	0.04	0.07	0.07	0.1
Stock-based compensation		0.56		0.12	0.23	0.07		0.13	0.02	0.01
Deferred income tax							0.03	0.02	-0.02	-0.01
Change in receivables	0.04	-0.19	0.02	0.15	-0	-0.65	0.35	-0.06	0.03	-0.04
Change in inventory		0.03	-0.08	-0.05	-0.07	0.07	-0.03	0.01	-0.18	-0.19
Change in payables	0.04	0.01	-0.09	-0.07
Cash from operations	-0.07	0.03	0.11	0.33	-0.06	0.5	0.55	0.32	0.28	0.38
Capital expenditures	-0	-0.02	-0.14	-0.04	-0.1	-0.14	-0.64	-0.32	-2.3	-3.57
Cash from investing	-0	-0.02	-0.13	-0.04	-0.11	-0.14	-0.64	-0.32	-2.3	-2.85
Cash from financing	0.04	-0.05	0.01	-0.03	0.16	-0.21	-0.09	0.07	2.12	2.41
Net change in cash			-0.01	0.26	-0.01	0.14	-0.18	0.07	0.11	-0.05
Free cash flow	-0.07	0.01	-0.03	0.29	-0.16	0.36	-0.09	-0	-2.01	-3.18
Interest paid	0.01	0.01		0	0	0.02	0.04	0.03	0.03	0.35
Income taxes paid			0.03	0.02					0.01

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $0.04 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	34.1%	Gross profit / revenue.
Operating margin	5.8%	Operating income / revenue.
EBITDA margin	7.4%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	7.3%	Pre-tax income / revenue.
Net margin	6.5%	Net income / revenue.
FCF margin	-15.5%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	8.2%	Cash from operations / revenue.
Return on equity (ROE)	10.8%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	3.4%	Net income / average total assets.
Return on invested capital (ROIC)	8.2%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Capex / revenue	23.6%	Capital expenditures / revenue.
D&A / revenue	1.6%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-2.4%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-0.0%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	2.2%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-6.3%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	0.8%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	-1.1%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-37.4%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	-11.4%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA growth, 1y	-25.2%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-4.0%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income growth, 1y	49.9%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	48.1%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow growth, 1y	34.1%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	-11.3%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value growth, 1y	18.0%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	13.9%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	18.3%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	46.7%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	35.2%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	33.3%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	0.0%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	0.7%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	4.3%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	0.76x	Current assets / current liabilities.
Quick ratio	0.37x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.14x	(Cash + short-term investments) / current liabilities.
Liabilities / assets	68.9%	Total liabilities / total assets.
Working capital	-$470.1K	Current assets - current liabilities.
Goodwill and intangibles / assets	6.1%	(Goodwill + intangible assets) / total assets.
Tangible book value	$2.8M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.52x	Revenue / average total assets.
Fixed asset turnover	0.64x	Revenue / average property, plant and equipment.
Inventory turnover	5.95x	Cost of revenue / average inventory.
Days inventory	61 days	365 x average inventory / cost of revenue.
Receivables turnover	13.5x	Revenue / average receivables.
Days sales outstanding	27 days	365 x average receivables / revenue.
FCF conversion	-237.6%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	290.0%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$0.00	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$0.03	Revenue / diluted weighted shares.
FCF per share	-$0.00	Free cash flow / diluted weighted shares.
Operating cash flow per share	$0.00	Cash from operations / diluted weighted shares.
Book value per share	$0.02	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$0.02	Tangible book value / shares outstanding.
Cash per share	$0.00	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$6.3M	Share price x shares outstanding.
Enterprise value	$6.1M	Market cap + total debt - cash - short-term investments.
P/E	16.6x	Market cap / net income. Only when net income is positive.
P/S	1.08x	Market cap / revenue.
P/B	1.80x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	2.23x	Market cap / tangible book value, when positive.
P/OCF	13.3x	Market cap / cash from operations, when positive.
EV/Sales	1.04x	Enterprise value / revenue.
EV/EBIT	17.9x	Enterprise value / operating income, when both are positive.
EV/EBITDA	14.0x	Enterprise value / EBITDA, when both are positive.
FCF yield	-14.3%	Free cash flow / market cap.
Earnings yield	6.0%	Net income / market cap (the inverse of P/E).

What was ADM ENDEAVORS, INC.'s revenue in fiscal 2025?

ADM ENDEAVORS, INC. reported revenue of $5.6M for fiscal 2025, 2.4% lower than the year before.

Was ADM ENDEAVORS, INC. profitable in fiscal 2025?

Yes. Net income was $486.3K, a net margin of 8.6%.

How much free cash flow did ADM ENDEAVORS, INC. generate in fiscal 2025?

Cash from operations of $381.1K minus capital expenditures of $3.6M left free cash flow of -$3.2M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to ADM ENDEAVORS, INC.